PPARGC1A and melanoma: PGC1α-mediated mitochondrial oxidative phosphorylation (OXPHOS) and PPARα-mediated fatty acid oxidation (FAO) are 2 metabolic pathways that have emerged as promising targets to overcome therapy resistance in melanoma (5–8).